Risk Evalutation and Mitigation Strategies

• 'Robustly enforce' chemical abortion regulations, Congressmen tell FDA
• Abortion drug companies exposed for endangering mothers in new report
• Abortion drugs now arrive as fast as an Amazon package
• Abortion pills or reversal - which is the real danger?
• As FDA reviews mifepristone, blue states petition FDA to remove abortion drug safety nets
• Biden admin “twisted” chemical abortion pill data, HHS Secy.
• Emergency room visits appear to rise after FDA relaxed abortion pill restrictions
• FDA abortion pill challenge delayed until after midterms
• FDA mifepristone review ongoing as pro-life groups demand action
• Federal appeals court rejects abortion drug maker’s challenge to pro-life West Virginia law
• Government will conduct abortion pill review amid studies showing possible dangers
• Louisiana seeks temporary return of in-person abortion pill requirement
• Louisiana, ADF challenge Biden-era abortion-by-mail scheme in pro-life states
• Reaching out to my local CVS pharmacy
• The abortion landscape is changing. So is the pro-life response.
• The abortion pill: So dangerous it needs a rare safety requirement
• Trump FDA nominee says he'll review in-person dispensing of mifepristone
• Trump FDA seeks pause on abortion pill lawsuit while it reviews drug's risks
• “Women should be valued and protected in pregnancy” – Heartbeat weighs in on abortion pill case